New York State Common Retirement Fund Century Therapeutics, Inc. Transaction History
New York State Common Retirement Fund
- $73.9 Billion
- Q3 2024
A detailed history of New York State Common Retirement Fund transactions in Century Therapeutics, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 13,743 shares of IPSC stock, worth $14,017. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,743
Previous 13,743
-0.0%
Holding current value
$14,017
Previous $35,000
31.43%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding IPSC
# of Institutions
67Shares Held
36.9MCall Options Held
8.7KPut Options Held
10.2K-
Bain Capital Life Sciences Investors, LLC Boston, MA5.41MShares$5.52 Million1.66% of portfolio
-
Vr Adviser, LLC New York, NY5.39MShares$5.5 Million0.95% of portfolio
-
Boxer Capital, LLC San Diego, CA3.9MShares$3.98 Million0.35% of portfolio
-
Casdin Capital, LLC New York, NY3.21MShares$3.28 Million0.43% of portfolio
-
Black Rock Inc. New York, NY2.9MShares$2.95 Million0.0% of portfolio
About Century Therapeutics, Inc.
- Ticker IPSC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,881,800
- Market Cap $60.1M
- Description
- Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...